Drug factory · FDA FEI 3009071264

Yabao Pharmaceutical Co., Ltd. Beijing

97 Kechuang East 6th Street, BDA, Beijing, China

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Mar 6, 2026.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

4 drug inspections on record since 2013: 1 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
CelecoxibMakes it Yabao Pharmaceutical Co., Ltd. Beijing 51990-033, 51990-034, 51990-035
GalantamineMakes it Slate Run Pharmaceuticals, LLC., Yabao Pharmaceutical Co., Ltd. Beijing 70436-004, 70436-005, 70436-006 +3
MetoprololMakes it Youngtech Pharmaceuticals, Inc. 69445-004, 69445-005, 69445-006
SorafenibMakes it Upsher-Smith Laboratories, Inc., Yabao Pharmaceutical Co., Ltd. Beijing 24979-715, 51990-201

FDA inspection history

EndedResultProgramProblems noted
Mar 6, 2026Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 20, 2022Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 3, 2015No problems foundDrug Quality Assurance—
Aug 16, 2013Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: manufacture.